liver-cancer

Documents about liver-cancer

• Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies#812123ClinicalTrials.gov
• Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis#838138ClinicalTrials.gov
• 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases#882681ClinicalTrials.gov
• Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases#896818ClinicalTrials.gov
• Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer#879875ClinicalTrials.gov
• Biobank for Cholestatic Liver Diseases.#840434ClinicalTrials.gov
• DEB-TACE Prior to Liver Transplantation in the Treatment of HCC#1045820ClinicalTrials.gov
• Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC#230409ClinicalTrials.gov
• Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer#808022ClinicalTrials.gov
• Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer#829323ClinicalTrials.gov
• FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis#841949ClinicalTrials.gov
• Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies#846721ClinicalTrials.gov
• Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer#857883ClinicalTrials.gov
• Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta#863901ClinicalTrials.gov
• Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer#865185ClinicalTrials.gov
• Hepatic Artery Infusion With Oxaliplatin#890061ClinicalTrials.gov
• The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer#905423ClinicalTrials.gov
• Antiviral Therapy for Patients With Liver Cancer After Surgery#980013ClinicalTrials.gov
• COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases#859510ClinicalTrials.gov
• Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer#982098ClinicalTrials.gov
• Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases#918554ClinicalTrials.gov
• Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival#802638ClinicalTrials.gov
• Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer#888549ClinicalTrials.gov
• Local Liver Treatment for Multi-organ Colorectal Cancer Metastases#125843ClinicalTrials.gov
• A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer#801254ClinicalTrials.gov
• Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer#803569ClinicalTrials.gov
• 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)#847950ClinicalTrials.gov
• Camrelizumab Utilization on Patients With Advanced Liver Cancer#849501ClinicalTrials.gov
• Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis#880593ClinicalTrials.gov
• Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions#394751ClinicalTrials.gov
• Liver CT Dose Reduction With Deep Learning Based Reconstruction#851647ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer#805798ClinicalTrials.gov
• A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors#804491ClinicalTrials.gov
• Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant#810951ClinicalTrials.gov
• A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma#910534ClinicalTrials.gov
• Pillars4Life Trial#806478ClinicalTrials.gov
• Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer#862875ClinicalTrials.gov
• Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma#892263ClinicalTrials.gov
• PrOspEctive Metastases Imaging (POEM)#917199ClinicalTrials.gov
• Volatile Organic Compounds for the Assessment of Liver Disease#862782ClinicalTrials.gov
• Comparison of Image Quality Between "Double Low Dose" Liver CT and Standard Liver CT#897390ClinicalTrials.gov
• Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases#900836ClinicalTrials.gov
• Minimally Invasive Simultaneous Colorectal and Liver Surgery#994239ClinicalTrials.gov
• Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease#869090ClinicalTrials.gov
• Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases#290987ClinicalTrials.gov
• Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.#813757ClinicalTrials.gov
• Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation#833234ClinicalTrials.gov
• Fluid Optimization in Liver Surgery#860903ClinicalTrials.gov
• Real-time Imaging of Holmium Radioembolization: a Feasibility Study#876055ClinicalTrials.gov
• TKM 080301 for Primary or Secondary Liver Cancer#914453ClinicalTrials.gov